Screening to detect multiple myeloma at its smouldering stage, however, is justifiable now, because early therapy has been shown to provide clinical benefit — but only in populations in which ...

Screening tests are not perfect and have some risks. The screening programme should also be good value for money for the NHS. What to do if you think you're at risk of myeloma. Talk to your GP if you ...

“For multiple myeloma, screening remains excluded from routine clinical practice today,” Habib El-Khoury, MD, postdoctoral research fellow at Dana-Farber Cancer Institute, told Healio.

VIDEO: Improved diagnosing, screening for multiple myeloma . Varshavsky-Yanovsky reports serving on advisory boards for Bristol Myers Squibb and Janssen; and consulting for Pfizer.

Simply knowing who to screen, and when, could reduce myeloma-related mortality rates, according to recent research. Simply knowing who to screen, and when, could reduce myeloma-related mortality rates ...

Joseph Mikhael, MD, and Irene Ghobrial, MD, discuss screening high-risk populations for early-stage multiple myeloma and new techniques to detect it.

Is there screening for smoldering multiple myeloma? There are no screening recommendations for SMM, so it is usually diagnosed by accident. As abnormal plasma cells accumulate, they release ...

"Myeloma symptoms are nonspecific, and therefore, a long diagnostic pathway is likely to continue if we rely upon health care workers to think of the diagnosis before a myeloma screen is performed ...

High-risk smoldering multiple myeloma (SMM) has emerged as the condition where treatment yields the greatest benefit, said S. Vincent Rajkumar, MD, professor of medicine at Mayo Clinic.

The targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments, studies suggest.